Anti-lactoferrin antibodies in systemic lupus erythematosus: Isotypes and clinical correlates

Clinical Rheumatology

Volumn 24, Issue 4, 2005, Pages 381-387

  Caccavo, Domenico ^a   Rigon, Amelia ^b   Picardi, Antonio ^b   Galluzzo, Sara ^c   Vadacca, Marta ^b   Ferri, Giovanni Maria ^c   Amoroso, Antonio ^c   Afeltra, Antonella ^b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anti lactoferrin antibodies; Lactoferrin; SLE

Indexed keywords

CARDIOLIPIN ANTIBODY; DNA ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; LACTOFERRIN ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OPTICAL DENSITY; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ADOLESCENT; ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; COHORT STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN ISOTYPES; LACTOFERRIN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 23344445225     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-1040-2     Document Type: Article

References (43)

1. Hoffman GS, Specks U (1998) Antineutrophil cytoplasmic antibodies. Arthritis Rheum 41:1521-1537 1:CAS:528:DyaK1cXmsVChtbs%3D
2. Bartunkova J, Tesar V, Sediva A (2003) Diagnostic and pathogenetic role of antineutrophil cytoplasmic autoantibodies. Clin Immunol 106:73-82 1:CAS:528:DC%2BD3sXisFSnsbc%3D
3. Van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Perman H, van Es LA, van der Giessen M, van der Hem GK, The TH (1985) Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1:425-429 2857806
4. Ludemann J, Utecht B, Gross WL (1990) Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 171:357-362 1:STN:280:By%2BC3M7mtlQ%3D
5. Falk RJ, Jennette JC (1988) Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 25:1651-1657
6. Anderson BF, Baker HM, Norris GE, Rice DW, Baker EN (1989) Structure of human lactoferrin: Crystallographic structure analysis and refinement at 2.8 Å resolution. J Mol Biol 209:711-734
7. Cramer E, Pryzwansky KB, Villeval JL, Testa U, Brenton-Gorius J (1985) Ultrastructural localization of lactoferrin and myeloperoxidase in human neutrophils by immunogold. Blood 65:423-432 1:CAS:528:DyaL2MXhs1eisLs%3D
8. Lash JA, Coates D, Lfuze J, Baehner RL, Boxer LA (1983) Plasma lactoferrin reflects granulocyte activation in vivo. Blood 61:885-888 1:CAS:528:DyaL3sXhvFKhtb8%3D
9. Sanchez L, Calvo M, Brock JH (1992) Biological role of lactoferrin. Arch Dis Child 67:657-661 1:STN:280:By2B1cnotlQ%3D
10. Levay PE, Viljoen M (1995) Lactoferrin: A general review. Haematologica 80:252-257 1:CAS:528:DyaK2MXoslGrsb0%3D
11. Caccavo D, Pellegrino NM, Altamura M, Rigon A, Amati L, Amoroso A, Jirillo E (2002) Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application. J Endotoxin Res 8:403-417 1:CAS:528:DC%2BD3sXptVOqsg%3D%3D
12. Peen E, Almer S, Bodemar G, Ryden BO, Sjolin C, Tejle K, Skogh T (1993) Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. Gut 34:56-62 1:STN:280:ByyC283ltV0%3D
13. Caradonna L, Amati L, Lella P, Jirillo E, Caccavo D (2000) Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease. Am J Gastroenterol 95:1495-1502 1:CAS:528:DC%2BD3cXkslCgsb8%3D
14. Coremans IEM, Hagen EC, Daha MR, van der Woude FJ, van der Voort EA, Kleijburg-van der Keur C, Breedveld FC (1992) Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum 35:1466-1475 1:STN:280:ByyC3M3hsVI%3D
15. Mulder AHL, Horst G, van Leeuwen MA, Limburg PC, Kallenberg CGM (1993) Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Arthritis Rheum 36:1054-1060 1:STN:280:ByyA2czps1w%3D
16. Afeltra A, Sebastiani GD, Galeazzi M, Caccavo D, Ferri GM, Marcolongo R, Bonomo L (1996) Antineutrophil cytoplasmic antibodies in synovial fluid and in serum of patients with rheumatoid arthritis and other types of synovitis. J Rheumatol 23:10-15 1:STN:280:BymH3srmtFI%3D
17. Locht T, Skogh T, Kihlström E (1999) Anti-lactoferrin antibodies and other types of anti-neutrophil cytoplasmic antibodies (ANCA) in reactive arthritis and ankylosing spondylitis. Clin Exp Immunol 117:568-573 1:CAS:528:DyaK1MXmtV2rs7w%3D
18. Lee SS, Lawton JWM, Chan CE, Li CS, Kwan TH, Chau KF (1992) Antilactoferrin antibody in systemic lupus erythematosus. Br J Rheumatol 31:669-673 1:STN:280:ByyD3cnosF0%3D
19. Schnabel A, Csernok E, Isenberg DA, Mrowka C, Gross WL (1995) Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance. Arthritis Rheum 38:633-637 1:STN:280:ByqB28jhtVQ%3D
20. Spronk PE, Bootsma H, Horst G, Huitema MG, Limburg PC, Tervaert JW, Kallenberg CG (1996) Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Br J Rheumatol 35:625-631 1:STN:280:BymA3c3kvVc%3D
21. Galeazzi M, Morozzi G, Sebastiani GD, Bellisai F, Marcolongo R, Cervera R, De Ramon Garrido E, Fernandez-Nebro A, Houssiau F, Jedryka-Goral A, Mathieu A, Papasteriades C, Piette JC, Scorza R, Smolen J (1998) Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: Prevalence, clinical associations and correlation with other autoantibodies. Clin Exp Rheumatol 16:541-546 1:STN:280:DyaK1cvlt1egtA%3D%3D
22. Chikazawa H, Nishiya K, Matsumori A, Hashimoto K (2000) Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases. J Clin Immunol 20:279-285 10.1023/ A:1006667703202
23. Nishiya K, Chikazawa H, Nishimura S, Hisakawa N, Hashimoto K (1997) Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features. Clin Rheumatol 16:70-75 1:STN:280:ByiB3crosVw%3D
24. Manolova I, Dancheva M, Halacheva K (2001) Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: Prevalence, antigen specificity, and clinical associations. Rheumatol Int 20:197-204 1:CAS:528:DC%2BD3MXmsF2qsrc%3D
25. Zhao MH, Liu N, Zhang YK, Wang HY (1998) Antineutrophil cytoplasmic autoantibodies (ANCA) and their target antigens in Chinese patients with lupus nephritis. Nephrol Dial Transplant 13:2821-2824 1:STN:280:DyaK1M%2FksV2nuw%3D%3D
26. Chin HJ, Ahn C, Lim CS, Chung HK, Lee JG, Song YW, Lee HS, Han JS, Kim S, Lee JS (2000) Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis. Am J Nephrol 20:57-63 1:STN:280:DC%2BD3c7ltlaitQ%3D%3D
27. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277 1:STN:280:BiyD2cfksFI%3D
28. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725 1:STN:280:ByiH28vitFU%3D
29. Liang MH, Socher SA, Larson MG, Schur PH (1989) Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 32:1107-1118 1:STN:280:BiaA2svjs1A%3D
30. Caccavo D, Laganà B, Mitterhofer AP, Ferri GM, Afeltra A, Amoroso A, Bonomo L (1997) Long-term treatment of systemic lupus erythematosus with cyclosporin A. Arthritis Rheum 40:27-35 1:CAS:528:DyaK2sXotFOqug%3D%3D
31. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42:599-608
32. Caccavo D, Afeltra A, Guido F, Di Monaco C, Ferri GM, Amoroso A, Vaccaio F, Bonomo L (1966) Two spatially distant epitopes of human lactoferrin. Hybridoma 15:263-269
33. Afeltra A, Caccavo D, Ferri GM, Addessi MA, De Rosa FG, Amoroso A, Bonomo L (1997) Expression of lactoferrin on human granulocytes: analysis with polyclonal and monoclonal antibodies. Clin Exp Immunol 109:279-285 1:CAS:528:DyaK2sXls1WjtL4%3D
34. Wiik A (2002) Neutrophil-specific autoantibodies in chronic inflammatory bowel diseases. Autoimmun Rev 1:67-72 1:CAS:528:DC%2BD38Xlt1Clsb4%3D
35. Amoroso A, Mitterhofer AP, Del Porto F, Garzia P, Ferri GM, Galluzzo S, Vadacca M, Caccavo D, Afeltra A (2003) Antibodies to anionic phospholipid and anti-β 2 -GPI: Association with thrombosis and thrombocytopenia in systemic lupus erythematosus. Human Immunol 64:265-273 1:CAS:528:DC%2BD3sXmsVyhtA%3D%3D
36. Manolova I, Dancheva M, Halacheva K (2002) Predominance of IgG1 and IgG3 subclasses of autoantibodies to neutrophil cytoplasmic antigens in patients with systemic lupus erythematosus. Rheumatol Int 21:227-233 1:CAS:528:DC%2BD38XktlOksbw%3D
37. Mulder AHL, Stegeman CA, Kallenberg CGM (1995) Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: A predominant role for the IgG3 subclass of ANCA. Clin Exp Immunol 101:227-232 1:STN:280:ByqA2snotVU%3D
38. Crouch SPM, Slater KJ, Fletcher J (1992) Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 80:235-240 1:CAS:528:DyaK38XkvVynsrw%3D
39. Machnicki M, Zimecki M, Zagulski T (1993) Lactoferrin regulates the release of tumor necrosis factor alpha and interleukin-6 in vivo. Int J Exp Pathol 74:433-439 1:CAS:528:DyaK2cXmt1yntrk%3D
40. Elass E, Masson M, Mazurier J, Legrand D (2002) Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infect Immun 70:1860-1866 1:CAS:528:DC%2BD38Xitl2murc%3D
41. Kievits F, Kijlstra A (1985) Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin. Immunology 54:449-456 1:CAS:528:DyaL2MXhsVOhtLc%3D
42. Falk RJ, Terrel RS, Charles LA, Jennette JC (1990) Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate, and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 87:4115-4119 1:CAS:528:DyaK3cXktlylu7w%3D
43. Mulder AHL, Heeringa P, Brouwer E, Limburg PC, Kallenberg CGM (1994) Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANChA): A Fc γRII-dependent process. Clin Exp Immunol 98:270-278 1:STN:280:ByqD2czlsFc%3D